Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tetratricopeptide repeat domain 34 pseudogene (LOC100421684, ENSG00000271632) is classified as a pseudogene, meaning it is a segment of DNA that resembles a gene but is nonfunctional in terms of protein-coding potential. It is not considered a therapeutic target, and there is no evidence it encodes a receptor, enzyme, transporter, or has a known biological activity. Some pseudogenes can produce noncoding RNAs that regulate the expression of related protein-coding genes through RNA interference and other mechanisms, and in rare cases are implicated in disease, but there is no evidence for such a function in this specific pseudogene[2][5].\nThe parent gene would have contained a tetratricopeptide repeat (TPR) structural motif, which is known for mediating protein-protein interactions in a wide range of scaffolding, cell cycle, and signaling proteins[1][4][6][7]. However, this pseudogene does not code for a functional TPR-domain protein[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tetratricopeptide repeat domain 34 pseudogene.